v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Expenses:    
General and administrative $ 483,404 $ 781,916
Total Operating Expenses 998,587 1,138,129
Loss From Operations (998,587) (1,138,129)
Other (Expense) Income:    
Total Other Expense (483,264) (137,277)
Net Loss (1,481,851) (1,275,406)
Dividend attributable to Series A, B, and C preferred stockholders (352,248) (326,665)
Net Loss Applicable to Common Stockholders $ (1,834,099) $ (1,602,071)
Net Loss Per Common Share - Basic $ (0.04) $ (0.04)
Net Loss Per Common Share - Diluted $ (0.04) $ (0.04)
Weighted Average Common Shares Outstanding - Basic 45,038,244 40,507,352
Weighted Average Common Shares Outstanding - Diluted 45,038,244 40,507,352
Nonrelated Party [Member]    
Operating Expenses:    
Research and development $ 500,683 $ 341,713
Other (Expense) Income:    
Interest expense (216,923) (64,804)
Interest expense - amortization of debt discount (6,686) (4,954)
Change in fair value of derivative and warrant liabilities 23,068 39,621
Related Party [Member]    
Operating Expenses:    
Research and development 14,500 14,500
Other (Expense) Income:    
Interest expense (210,314) (158,010)
Interest expense - amortization of debt discount (79,951) (1,002)
Change in fair value of derivative and warrant liabilities $ 7,542 $ 51,872